XML 107 R95.htm IDEA: XBRL DOCUMENT v3.22.1
Other Income and Expense (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure of other operating income (expense) [Abstract]  
Summary of Other Income
(1)
Other income for the years ended December 31, 2019, 2020 and 2021 are as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
2019
    
2020
    
2021
 
          
In millions of won
 
Reversal of other provisions
           16,542        25,826        15,548  
Reversal of other allowance for doubtful accounts
             —          2,465        98  
Gains on government grants
             281        269        458  
Gains on assets contributed
             6,921        24,324        9,347  
Gains on liabilities exempted
             916        1,314        1,830  
Compensation and reparations revenue
             113,292        95,407        104,826  
Revenue from foundation fund
             —          —          1  
Revenue from research contracts
             5,276        4,001        5,996  
Income related to transfer of assets from customers
             604,808        643,477        661,212  
Rental income
             191,088        193,567        204,123  
Others
             58,849        45,798        30,694  
            
 
 
    
 
 
    
 
 
 
             997,973        1,036,448        1,034,133  
            
 
 
    
 
 
    
 
 
 
Summary of Details of Others of Other Income
(2)
Details of “others” included in other income for the years ended December 31, 2019, 2020 and 2021 are as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
2019
    
2020
    
2021
 
          
In millions of won
 
Refund of claim for rectification
           1,969        11,880        7,274  
Adjustment of research project
             3,294        2,150        7,638  
Maintenance expenses on lease building
             153        2,785        160  
Training expenses
             3,167        3,852        1,739  
Deposit redemption
             436        314        378  
Reversal of expenses on litigation
             9,926        620        991  
Revenue on royalty fee
             —          —          173  
Reimbursement of insurance fee
             610        22        1  
Gains on guarantee contracts
             135        134        27  
Others
             39,159        24,041        12,313  
            
 
 
    
 
 
    
 
 
 
               58,849             45,798             30,694  
            
 
 
    
 
 
    
 
 
 
Summary of Other Expense
(3)
Other expenses for the years ended December 31, 2019, 2020 and 2021 are as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
2019
    
2020
    
2021
 
          
In millions of won
 
Compensation and indemnification expense
           403        11,959        663  
Accretion expenses of other provisions
             7,939        17,991        2,711  
Depreciation expenses on investment properties
             5,069        1,453        1,386  
Depreciation expenses on idle assets
             6,542        6,604        3,621  
Other bad debt expense
             29,348        32,503        49,372  
Donations
             64,752        316,981        152,456  
Others
             127,860        30,229        47,723  
            
 
 
    
 
 
    
 
 
 
             241,913        417,720        257,932  
            
 
 
    
 
 
    
 
 
 
Summary of Others of Other Expense
(4)
Details of “others” included in other expenses for the years ended December 31, 2019, 2020 and 2021 are as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
2019
    
2020
    
2021
 
          
In millions of won
 
Operating expenses related to the idle assets
           49        46        44  
Research grants
             399        91        109  
Expenses related to
farming and fishing village
 supports
             13,991        16,115        17,065  
Expenses related to 
Operating
of a
fitness center
             5,234        5,101        6,948  
Expenses on adjustment of research and development grants
             554        720        2,241  
Taxes and dues
             188        253        119  
Expenses on R&D
supports
             67        242        861  
Others
             107,378        7,661        20,336  
            
 
 
    
 
 
    
 
 
 
             127,860          30,229          47,723